Ben Goldacre
#1,564
Most Influential Person Now
British science writer and doctor
Ben Goldacre's AcademicInfluence.com Rankings
Ben Goldacremedical Degrees
Medical
#14
World Rank
#30
Historical Rank
Epidemiology
#281
World Rank
#298
Historical Rank
Ben Goldacrephilosophy Degrees
Philosophy
#2043
World Rank
#3573
Historical Rank
Logic
#3554
World Rank
#4736
Historical Rank
Download Badge
Medical Philosophy
Ben Goldacre's Degrees
- Bachelors Medicine University of Oxford
- Bachelors Philosophy, Politics, and Economics University of Oxford
- PhD Medicine University of Oxford
Why Is Ben Goldacre Influential?
(Suggest an Edit or Addition)According to Wikipedia, Ben Michael Goldacre is a British physician, academic and science writer. He is the first Bennett Professor of Evidence-Based Medicine and director of the Bennett Institute for Applied Data Science at the University of Oxford. He is a founder of the AllTrials campaign and OpenTrials to require open science practices in clinical trials.
Ben Goldacre's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Factors associated with COVID-19-related death using OpenSAFELY (2020) (2942)
- OpenSAFELY: factors associated with COVID-19 death in 17 million patients (2020) (1737)
- OpenSAFELY: factors associated with COVID-19-related hospital death in the linked electronic health records of 17 million adult NHS patients. (2020) (641)
- Functional heterogeneity of left inferior frontal cortex as revealed by fMRI (1997) (260)
- Test, Learn, Adapt: Developing Public Policy with Randomised Controlled Trials | Cabinet Office (2012) (233)
- Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform (2021) (233)
- Why clinical trial outcomes fail to translate into benefits for patients (2017) (212)
- Bad Pharma: How Drug Companies Mislead Doctors and Harm Patients (2012) (187)
- What proportion of symptomatic side effects in patients taking statins are genuinely caused by the drug? Systematic review of randomized placebo-controlled trials to aid individual patient choice (2014) (183)
- Who Owns the Data? Open Data for Healthcare (2016) (178)
- Impact of statin related media coverage on use of statins: interrupted time series analysis with UK primary care data (2016) (176)
- Risk of COVID-19-related death among patients with chronic obstructive pulmonary disease or asthma prescribed inhaled corticosteroids: an observational cohort study using the OpenSAFELY platform (2020) (174)
- Pragmatic randomised trials using routine electronic health records: putting them to the test (2012) (167)
- HIV infection and COVID-19 death: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform (2020) (165)
- Building evidence into education (2013) (164)
- The opportunities and challenges of pragmatic point-of-care randomised trials using routinely collected electronic records: evaluations of two exemplar trials. (2014) (161)
- Case fatality risk of the SARS-CoV-2 variant of concern B.1.1.7 in England, 16 November to 5 February (2021) (156)
- Compliance with requirement to report results on the EU Clinical Trials Register: cohort study and web resource (2018) (124)
- Opioid prescribing trends and geographical variation in England, 1998-2018: a retrospective database study. (2019) (124)
- HIV infection and COVID-19 death: a population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform (2020) (123)
- Atypical antipsychotic augmentation in SSRI treatment refractory obsessive-compulsive disorder: a systematic review and meta-analysis (2014) (122)
- COMPare: a prospective cohort study correcting and monitoring 58 misreported trials in real time (2019) (120)
- Compliance with legal requirement to report clinical trial results on ClinicalTrials.gov: a cohort study (2020) (119)
- Factors associated with deaths due to COVID-19 versus other causes: population-based cohort analysis of UK primary care data and linked national death registrations within the OpenSAFELY platform (2021) (97)
- Evidence based medicine manifesto for better healthcare (2017) (86)
- Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records (2022) (83)
- Big health data: the need to earn public trust (2016) (82)
- Temporal trends in use of tests in UK primary care, 2000-15: retrospective analysis of 250 million tests (2018) (81)
- Survival Analysis of Irish Amyotrophic Lateral Sclerosis Patients Diagnosed from 1995–2010 (2013) (79)
- Catalogue of bias: publication bias (2018) (73)
- Prediction of Cardiovascular Risk Using Framingham, ASSIGN and QRISK2: How Well Do They Predict Individual Rather than Population Risk? (2014) (69)
- Statin treatment and muscle symptoms: series of randomised, placebo controlled n-of-1 trials (2021) (66)
- Trends and clinical characteristics of COVID-19 vaccine recipients: a federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY (2021) (63)
- Use of non-steroidal anti-inflammatory drugs and risk of death from COVID-19: an OpenSAFELY cohort analysis based on two cohorts (2021) (63)
- Linked electronic health records for research on a nationwide cohort of more than 54 million people in England: data resource (2021) (62)
- Trends, regional variation, and clinical characteristics of COVID-19 vaccine recipients: a retrospective cohort study in 23.4 million patients using OpenSAFELY. (2021) (62)
- OpenTrials: towards a collaborative open database of all available information on all clinical trials (2016) (62)
- The quality of the evidence for dietary advice given in UK national newspapers (2012) (62)
- Risks of covid-19 hospital admission and death for people with learning disability: population based cohort study using the OpenSAFELY platform (2021) (60)
- How to Get All Trials Reported: Audit, Better Data, and Individual Accountability (2015) (60)
- The efficiency of cardiovascular risk assessment: do the right patients get statin treatment? (2013) (59)
- Association between living with children and outcomes from covid-19: OpenSAFELY cohort study of 12 million adults in England (2020) (59)
- Trials of transvaginal mesh devices for pelvic organ prolapse: a systematic database review of the US FDA approval process (2017) (58)
- Lack of evidence for interventions offered in UK fertility centres (2016) (58)
- Claims for fertility interventions: a systematic assessment of statements on UK fertility centre websites (2016) (56)
- Are clinical trial data shared sufficiently today? No (2013) (55)
- Severity of SARS-CoV-2 alpha variant (B.1.1.7) in England. (2021) (52)
- The TrialsTracker: Automated ongoing monitoring of failure to share clinical trial results by all major companies and research institutions (2016) (52)
- How medicine is broken, and how we can fix it (2015) (51)
- Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017 (2018) (51)
- Risk factors for long COVID: analyses of 10 longitudinal studies and electronic health records in the UK (2021) (51)
- Benefits and harms of pregabalin in the management of neuropathic pain: a rapid review and meta-analysis of randomised clinical trials (2019) (50)
- Time trends and geographical variation in prescribing of antibiotics in England 1998–2017 (2018) (49)
- Prevalence of clinical trial status discrepancies: A cross-sectional study of 10,492 trials registered on both ClinicalTrials.gov and the European Union Clinical Trials Register (2018) (47)
- Pharmaceutical companies’ policies on access to trial data, results, and methods: audit study (2017) (47)
- Clinical coding of long COVID in English primary care: a federated analysis of 58 million patient records in situ using OpenSAFELY (2021) (46)
- Transvaginal mesh failure: lessons for regulation of implantable devices (2017) (46)
- Effect of pre-exposure use of hydroxychloroquine on COVID-19 mortality: a population-based cohort study in patients with rheumatoid arthritis or systemic lupus erythematosus using the OpenSAFELY platform (2020) (44)
- Text messaging reminders for influenza vaccine in primary care: a cluster randomised controlled trial (TXT4FLUJAB) (2016) (40)
- Bad Science: Quacks, Hacks, and Big Pharma Flacks (2008) (39)
- Benefits and risks of homoeopathy (2007) (39)
- Assessment of Conflicts of Interest in Robotic Surgical Studies: Validating Author's Declarations With the Open Payments Database (2017) (37)
- OpenPrescribing: normalised data and software tool to research trends in English NHS primary care prescribing 1998–2016 (2018) (37)
- Ethnic differences in COVID-19 infection, hospitalisation, and mortality: an OpenSAFELY analysis of 17 million adults in England (2020) (36)
- Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials.gov: a cross-sectional study (2014) (35)
- Why researchers should share their analytic code (2019) (32)
- Noncommercial Funders’ Policies on Trial Registration, Access to Summary Results, and Individual Patient Data Availability (2018) (30)
- Cancer Drugs Fund requires further reform (2016) (30)
- Mass treatment with statins (2014) (29)
- High reprint orders in medical journals and pharmaceutical industry funding: case-control study (2012) (28)
- Variation in responsiveness to warranted behaviour change among NHS clinicians: novel implementation of change detection methods in longitudinal prescribing data (2019) (28)
- COMPare Trials Project (2016) (28)
- Is the conflict of interest unacceptable when drug companies conduct trials on their own drugs? Yes (2009) (26)
- Preventing bad reporting on health research (2014) (25)
- Open letter: European Medicines Agency should remove barriers to access clinical trial data (2014) (24)
- Media misinformation and health behaviours. (2009) (24)
- Evidence based medicine manifesto for better healthcare (2017) (24)
- Make journals report clinical trials properly (2016) (23)
- Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an observational study of 4.3 million adults over the age of 65 (2022) (22)
- Bicycle helmets and the law (2013) (22)
- Interpretive Bias in Acupuncture Research? (2009) (21)
- Inhaled corticosteroid use and risk COVID-19 related death among 966,461 patients with COPD or asthma: an OpenSAFELY analysis (2020) (21)
- Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform (2022) (21)
- Why did some practices not implement new antibiotic prescribing guidelines on urinary tract infection? A cohort study and survey in NHS England primary care (2018) (20)
- Describing the population experiencing COVID-19 vaccine breakthrough following second vaccination in England: a cohort study from OpenSAFELY (2021) (19)
- Trends and variation in prescribing of low-priority treatments identified by NHS England: a cross-sectional study and interactive data tool in English primary care (2017) (19)
- Practice variation in the use of tests in UK primary care: a retrospective analysis of 16 million tests performed over 3.3 million patient years in 2015/16 (2018) (19)
- Waning effectiveness of BNT162b2 and ChAdOx1 covid-19 vaccines over six months since second dose: OpenSAFELY cohort study using linked electronic health records (2022) (18)
- MMR: the scare stories are back (2007) (18)
- Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe COVID-19 outcomes in non-hospitalised patients: an observational cohort study using the OpenSAFELY platform (2022) (18)
- COVID-19 trajectories among 57 million adults in England: a cohort study using electronic health records (2022) (17)
- FDAAA TrialsTracker: A live informatics tool to monitor compliance with FDA requirements to report clinical trial results (2018) (17)
- Factors associated with the prescribing of high-dose opioids in primary care: a systematic review and meta-analysis (2020) (16)
- Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform (2021) (16)
- Comparative effectiveness of ChAdOx1 versus BNT162b2 covid-19 vaccines in health and social care workers in England: cohort study using OpenSAFELY (2021) (16)
- Do doctors in dispensing practices with a financial conflict of interest prescribe more expensive drugs? A cross-sectional analysis of English primary care prescribing data (2019) (16)
- Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net (2018) (16)
- Comparative effectiveness of sotrovimab and molnupiravir for prevention of severe covid-19 outcomes in patients in the community: observational cohort study with the OpenSAFELY platform (2022) (15)
- Improving, and auditing, access to clinical trial results (2014) (15)
- Rethinking the appraisal and approval of drugs for type 2 diabetes (2015) (15)
- Impact of first UK COVID-19 lockdown on hospital admissions: Interrupted time series study of 32 million people (2022) (15)
- Study protocol for statin web-based investigation of side effects (StatinWISE): a series of randomised controlled N-of-1 trials comparing atorvastatin and placebo in UK primary care (2017) (15)
- Why Cochrane should prioritise sharing data (2018) (15)
- COMPare: Qualitative analysis of researchers’ responses to critical correspondence on a cohort of 58 misreported trials (2019) (14)
- The NHS deserves better use of hospital medicines data (2020) (14)
- Funding source and primary outcome changes in clinical trials registered on ClinicalTrials.gov are associated with the reporting of a statistically significant primary outcome: a cross-sectional study. (2015) (14)
- Trends, geographical variation and factors associated with prescribing of gluten-free foods in English primary care: a cross-sectional study (2018) (14)
- Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis (2018) (14)
- Why the GMC should set up a central registry of doctors’ competing interests (2014) (14)
- The WHO joint statement from funders on trials transparency (2017) (13)
- OpenSAFELY: Representativeness of electronic health record platform OpenSAFELY-TPP data compared to the population of England (2022) (13)
- Impact of Chief Medical Officer activity on prescribing of antibiotics in England: an interrupted time series analysis (2019) (12)
- OpenSAFELY: impact of national guidance on switching from warfarin to direct oral anticoagulants (DOACs) in early phase of COVID-19 pandemic in England (2020) (12)
- Identifying Care Home Residents in Electronic Health Records - An OpenSAFELY Short Data Report (2021) (12)
- Getting our house in order: an audit of the registration and publication of clinical trials supported by the National Institute for Health Research Oxford Biomedical Research Centre and the Musculoskeletal Biomedical Research Unit (2016) (12)
- Meta-analysis of side effects of statins shows need for trial transparency (2014) (11)
- Focus on sharing individual patient data distracts from other ways of improving trial transparency (2017) (11)
- Evaluation of Compliance With Legal Requirements Under the FDA Amendments Act of 2007 for Timely Registration of Clinical Trials, Data Verification, Delayed Reporting, and Trial Document Submission. (2021) (11)
- Trends and variation in unsafe prescribing of methotrexate: a cohort study in English NHS primary care (2019) (11)
- Tell us the truth about nutritionists (2007) (10)
- Abortion and mental health: guidelines for proper scientific conduct ignored (2012) (10)
- Developing Public Policy with Randomised Controlled Trials (2019) (10)
- Trends in antidepressant prescribing in England. (2021) (10)
- New mechanism to identify cost savings in English NHS prescribing: minimising ‘price per unit’, a cross-sectional study (2018) (10)
- OpenSAFELY: impact of national guidance on switching anticoagulant therapy during COVID-19 pandemic (2021) (9)
- Six months on: NHS England needs to focus on dissemination, implementation and audit of its low-priority initiative (2018) (9)
- Detecting change in comparison to peers in NHS prescribing data: a novel application of cumulative sum methodology (2018) (9)
- Trends and variation in antidepressant prescribing in English primary care: a retrospective longitudinal study (2021) (9)
- Randomised Evaluations of Accepted Choices in Treatment (REACT) trials: large-scale pragmatic trials within databases of routinely collected electronic healthcare records (2011) (9)
- Discrepancies Between Prespecified and Reported Outcomes (2016) (9)
- Measuring the Impact of an Open Web-Based Prescribing Data Analysis Service on Clinical Practice: Cohort Study on NHS England Data (2019) (9)
- Prescribing biosimilars (2018) (9)
- OpenSAFELY NHS Service Restoration Observatory 1: primary care clinical activity in England during the first wave of COVID-19 (2021) (8)
- Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care (2019) (8)
- OpenSAFELY: Risks of COVID-19 hospital admission and death for people with learning disabilities - a cohort study. (2021) (8)
- OpenSAFELY NHS Service Restoration Observatory 1: describing trends and variation in primary care clinical activity for 23.3 million patients in England during the first wave of COVID-19 (2021) (8)
- A cross-sectional study of all clinicians’ conflict of interest disclosures to NHS hospital employers in England 2015-2016 (2018) (7)
- Barriers to Health Information and Building Solutions (2011) (7)
- Suboptimal prescribing behaviour associated with clinical software design features: a retrospective cohort study in English NHS primary care. (2020) (7)
- We should push for evidence based sentencing in criminal justice (2011) (7)
- Problems with ethical approval and how to fix them: lessons from three trials in rheumatoid arthritis (2016) (7)
- Prescription of suboptimal statin treatment regimens: a retrospective cohort study of trends and variation in English primary care (2020) (7)
- Association between warfarin and COVID-19-related outcomes compared with direct oral anticoagulants: population-based cohort study (2021) (7)
- Is use of homeopathy associated with poor prescribing in English primary care? A cross-sectional study (2018) (6)
- The clinician impact and financial cost to the NHS of litigation over pregabalin: a cohort study in English primary care (2018) (6)
- The poor performance of apps assessing skin cancer risk (2020) (6)
- Sales of Over-the-Counter Products Containing Codeine in 31 Countries, 2013–2019: A Retrospective Observational Study (2021) (6)
- OpenSAFELY: Do adults prescribed Non-steroidal anti-inflammatory drugs have an increased risk of death from COVID-19? (2020) (6)
- The next steps on Zika (2016) (6)
- Trends and clinical characteristics of 57.9 million COVID-19 vaccine recipients: a federated analysis of patients' primary care records in situ using OpenSAFELY. (2021) (6)
- Safety of COVID-19 vaccination and acute neurological events: A self-controlled case series in England using the OpenSAFELY platform (2022) (6)
- Barriers to Working With National Health Service England’s Open Data (2019) (6)
- A comprehensive high cost drugs dataset from the NHS in England - An OpenSAFELY-TPP Short Data Report (2021) (5)
- Commentary on Berlin et al. (2014) (5)
- How doctors can get behind the headlines (2007) (5)
- All BMJ research papers should share their analytic code (2016) (5)
- Journalists: anything to declare? (2007) (5)
- Blackpool Teaching Hospitals NHS Foundation Trust (2018) (5)
- Bringing NHS data analysis into the 21st century (2020) (5)
- Barts Health NHS Trust (2018) (5)
- Changes in COVID-19-related mortality across key demographic and clinical subgroups: an observational cohort study using the OpenSAFELY platform on 18 million adults in England (2022) (5)
- Fixing flaws in science must be professionalized. (2016) (4)
- Personalised Medicine Using N-of-1 Trials: Overcoming Barriers to Delivery (2019) (4)
- Commentary: Randomized trials of controversial social interventions: slow progress in 50 years. (2015) (4)
- Association between oral anticoagulants and COVID-19 related outcomes: two cohort studies (2021) (4)
- European non-commercial sponsors showed substantial variation in results reporting to the EU trial registry. (2021) (4)
- Meta-analyses of homoeopathy trials – Author's reply (2008) (4)
- Problems with ABPI proposals to release data on payments to doctors (2014) (4)
- Study protocol: Comparison of different risk prediction modelling approaches for COVID-19 related death using the OpenSAFELY platform (2020) (4)
- Evaluating the impact of a very low-cost intervention to increase practices' engagement with data and change prescribing behaviour: a randomized trial in English primary care. (2021) (4)
- Preventable suicides: a systematic analysis of coroners’ prevent future death reports in England and Wales (2020) (4)
- Changes in the rate of cardiometabolic and pulmonary events during the COVID-19 pandemic (2021) (4)
- You can now search FDA approval documents easily at fda.opentrials.net (2017) (4)
- Trends and variation in data quality and availability on the European Union Clinical Trials Register: A cross-sectional study (2022) (4)
- Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19 in England: a descriptive cohort study within the OpenSAFELY platform (2022) (4)
- Overcoming Barriers to Working With NHS Open Data (Preprint) (2019) (4)
- Changes in English medication safety indicators throughout the COVID-19 pandemic: a federated analysis of 57 million patients' primary care records in situ using OpenSAFELY (2022) (4)
- Impact Of Electronic Health Record Interface Design On Unsafe Prescribing Of Ciclosporin, Tacrolimus and Diltiazem: A Cohort Study In English NHS Primary Care (2019) (4)
- Mortality among Care Home Residents in England during the first and second waves of the COVID-19 pandemic: an analysis of 4.3 million adults over the age of 65 (2021) (3)
- Association between household composition and severe COVID-19 outcomes in older people by ethnicity: an observational cohort study using the OpenSAFELY platform (2022) (3)
- Trends, regional variation and clinical characteristics of recipients of antivirals and neutralising monoclonal antibodies for non-hospitalised COVID-19: a descriptive cohort study of 23.4 million people in OpenSAFELY (2022) (3)
- Factors associated with COVID-19 vaccine uptake in people with kidney disease: an OpenSAFELY cohort study (2022) (3)
- Funding source and primary outcome changes in clinical trials registered on ClinicalTrials.gov are associated with the reporting of a statistically significant primary outcome: a cross-sectional study (2015) (3)
- Comparative effectiveness of sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients on kidney replacement therapy: observational cohort study using the OpenSAFELY-UKRR linked platform and SRR database (2022) (3)
- Why don't journalists mention the data? (2007) (3)
- OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care activity across six clinical areas during the COVID-19 pandemic (2022) (3)
- Comparative effectiveness of BNT162b2 versus mRNA-1273 boosting in England: a cohort study in OpenSAFELY-TPP (2022) (3)
- Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY (2022) (3)
- Guidelines for collaboration with industry should be transparent (2013) (3)
- Outcomes in the trial registry should match those in the protocol (2016) (3)
- Author Correction: Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net (2018) (3)
- Ethnic disparities in COVID-19: increased risk of infection or severe disease? – Authors' reply (2021) (3)
- Hydroxychloroquine for prevention of COVID-19 mortality: a population-based cohort study (2020) (3)
- Book Review: Book Reviews - Bad Science (2009) (3)
- Comparative effectiveness of Paxlovid versus sotrovimab and molnupiravir for preventing severe COVID-19 outcomes in non-hospitalised patients: observational cohort study using the OpenSAFELY platform (2023) (2)
- Trends, variation, and clinical characteristics of recipients of antiviral drugs and neutralising monoclonal antibodies for covid-19 in community settings: retrospective, descriptive cohort study of 23.4 million people in OpenSAFELY (2023) (2)
- I Think You'll Find It's a Bit More Complicated Than That (2014) (2)
- Short report: Ethnicity and COVID-19 death in the early part of the COVID-19 second wave in England: an analysis of OpenSAFELY data from 1st September to 9th November 2020 (2021) (2)
- Projected spending for brand-name drugs in English primary care given US prices: a cross-sectional study (2020) (2)
- Measuring the Impact of an Open Online Prescribing Data Analysis Service on Clinical Practice: a Cohort Study in NHS England Data (2018) (2)
- The effect of statins on muscle symptoms in primary care: the StatinWISE series of 200 N-of-1 RCTs. (2021) (2)
- Accident and emergency (AE) attendance in England following infection with SARS-CoV-2 Omicron or Delta (2022) (2)
- Royal College examination fees surplus (2012) (2)
- NICE must do better at summarising and communicating evidence on statins (2014) (2)
- A New Mechanism To Identify Cost Savings in NHS Prescribing: Minimising “Price-Per-Unit” (2017) (2)
- Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: cohort study in OpenSAFELY using linked primary care, secondary care and death registration data (2021) (2)
- Given the choice, I'd have the miracle pill story (2007) (2)
- When the facts get in the way of a story (2007) (2)
- Recording of 'COVID-19 vaccine declined' among vaccination priority groups: a cohort study on 57.9 million NHS patients' primary care records in situ using OpenSAFELY (2021) (2)
- Evidence on industry influence should be in the core medical curriculum (2014) (2)
- Cardiovascular outcome trials of glucose-lowering strategies in type 2 diabetes (2014) (2)
- Potentially inappropriate prescribing of DOACs to people with mechanical heart valves: A federated analysis of 57.9 million patients' primary care records in situ using OpenSAFELY. (2022) (2)
- Correction: Variation in diagnostic test requests and outcomes: A preliminary metric for OpenPathology.net (Scientific Reports DOI: 10.1038/s41598-018-23263-z) (2018) (2)
- Trends and Variation in Data Quality on the EU Clinical Trials Register: A Cross-Sectional Study (2021) (1)
- ebmdatalab/fdaaa_trends: Code to assess compliance with FDAAA 2007 (2020) (1)
- The CONFIDeNT trial (2016) (1)
- Trends and variation in prescribing of suboptimal statin treatment regimes: a cohort study in English primary care (2019) (1)
- Beware of mentioning psychosocial factors (2007) (1)
- Antivirals, pandemic planning, and failure to heed calls for trial data (2015) (1)
- Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net (2018) (1)
- Eleven key measures for monitoring general practice clinical activity during COVID-19 using federated analytics on 48 million adults' primary care records through OpenSAFELY (2022) (1)
- Postoperative mortality and complications in patients with and without pre‐operative SARS‐CoV‐2 infection: a service evaluation of 24 million linked records using OpenSAFELY (2023) (1)
- Preventing bad reporting on health research: Academics should be made accountable for exaggerations in press releases about their own work (2014) (1)
- Does The Reformed Cancer Drug Fund Generate Evidence On Effectiveness? A Cross-sectional Analysis On Publicly Accessible Documentation (2020) (1)
- Value of information analysis for eLung (2014) (1)
- Hydroxychloroquine treatment does not reduce COVID-19 mortality; underdosing to the wrong patients? – Authors' reply (2021) (1)
- Software development skills for health data researchers (2022) (1)
- Data set of primary outcome changes in interventional clinical trials registered on ClinicalTrials.org (2014) (1)
- Transparency of the UK medicines regulator: auditing freedom of information requests and reasons for refusal (2018) (1)
- 135 Trends and variation in the sales of over-the-counter analgesics: a protocol for a retrospective database study and policy review (2018) (1)
- Don't Dumb Me down. (2007) (1)
- Association between oral anticoagulants and COVID-19-related outcomes: a population-based cohort study (2022) (1)
- Comparative effectiveness of two- and three-dose schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study (2022) (1)
- Trends, geographic variation, and factors associated with prescribing of gluten-free foods in English primary care: a cross sectional study (2017) (1)
- Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway: a cohort study using OpenSAFELY-TPP (2022) (1)
- Pregabalin: what the patent litigation means for doctors and drug companies (2018) (1)
- Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform (2023) (1)
- E-cigarette manufacturers’ compliance with clinical trial reporting expectations: a case series of registered trials by Juul Labs (2021) (1)
- Too few trials or too few reported trials? (2018) (1)
- Bicycle helmets and the law: Canadian legislation had minimal effect on serious head injuries (2013) (1)
- Point-of-care trials: the way forward– perspectives from patient representatives and general practitioner investigators (2014) (1)
- Predicting COVID-19 related death using the OpenSAFELY platform (2021) (1)
- Identifying Patterns of Clinical Interest in Clinicians’ Treatment Preferences: Hypothesis-free Data Science Approach to Prioritizing Prescribing Outliers for Clinical Review (2022) (1)
- Cancer Drugs Fund requires further reform : Reliance on “real world” observational data undermines evidence base for clinical practice (2016) (1)
- New EU trial reporting regulations must be enforced (2022) (0)
- First dose COVID-19 vaccine coverage amongst adolescents and children in England: an analysis of 3.21 million patients' primary care records in situ using OpenSAFELY (2023) (0)
- Qualitative research of views on computerised trial recruitment for the information technology system design (2014) (0)
- Editors Need to Deliver Better Science (2016) (0)
- Harnessing value of dispersed critiques (2011) (0)
- Author Correction: Variation in diagnostic test requests and outcomes: a preliminary metric for OpenPathology.net (2018) (0)
- A National Audit of Pancreatic Enzyme Prescribing in Pancreatic Cancer from 2015 to 2023 in England Using OpenSAFELY-TPP. (2023) (0)
- Challenges in Estimating the Effectiveness of COVID-19 Vaccination Using Observational Data (2023) (0)
- Data-Driven Identification of Unusual Prescribing Behavior: Analysis and Use of an Interactive Data Tool Using 6 Months of Primary Care Data From 6500 Practices in England (2023) (0)
- Lewisham and Greenwich NHS Trust (2018) (0)
- Effectiveness of an internet-delivered handwashing intervention (2016) (0)
- Data-driven identification of unusual prescribing behaviour: an analysis and interactive data tool using six months of primary care data from 6500 practices in England (2022) (0)
- Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis” (2018) (0)
- ebmdatalab/opensafely-risk-factors-research (2020) (0)
- Scientific challenges in point-of-care trials (2014) (0)
- Clinical trial reporting – Authors' reply (2020) (0)
- Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis (2018) (0)
- 65 Factors and variation driving inappropriate opioid analgesic prescribing in the community: a systematic review protocol (2018) (0)
- Book Review: Bad Science (2009) (0)
- dual-registered trial data 26/07/17 (2018) (0)
- The Market's Adverse Effects (2014) (0)
- Trial methodology used in this project (2014) (0)
- Challenges in estimating waning effectiveness of two doses of BNT162b2 and ChAdOx1 COVID-19 vaccines beyond six months: an OpenSAFELY cohort study using linked electronic health records (2023) (0)
- Charters for Trial Steering and Data Monitoring Committees (2014) (0)
- OpenSAFELY NHS Service Restoration Observatory 2: changes in primary care clinical activity in England during the COVID-19 pandemic (2023) (0)
- Discussion, recommendations and guidance (2014) (0)
- The impact of lidocaine plaster prescribing reduction strategies: a comparison of two national health services in Europe (2023) (0)
- Canadian Surgery Forum 2018: St. John's, NL Sept. 13-15, 2018. (2018) (0)
- Oxford Trial Audit data collection template (2015) (0)
- In his new book Ben Goldacre argues that the pharmaceutical industry is in poor health and in urgent need of treatment. Richard Smith agrees. (2012) (0)
- Behold the Christmas miracle of antioxidants (2007) (0)
- Supporting data for general practitioner views and experiences of point-of-care trials (the Qualitative process Evaluation of ANtibiotics study results) (2014) (0)
- Prescription data for open toe sandals syndrome (2017) (0)
- OpenPrescribing.net: an open online tool for audit, feedback and alerts on quality, safety and cost-effectiveness of prescribing in primary care. (2019) (0)
- The Qualitative process Evaluation of ANtibiotics study: general practitioner andpatientinterview topic guides (2014) (0)
- The Authors Respond. (2020) (0)
- Books Reviewed (2009) (0)
- The PRINTO juvenile dermatomyositis trial (2016) (0)
- Trial recruitment and data collection (2014) (0)
- Statin treatment and muscle symptoms (2021) (0)
- Authors’ reply to Beales (2017) (0)
- PATHWAY-2: spironolactone for resistant hypertension (2016) (0)
- Outcomes in the EXAMINATION trial (2016) (0)
- Open Heart – The new BMJ cardiovascular journal, advocating open access, open peer-review and open data (2013) (0)
- The impact of the COVID-19 pandemic on Antipsychotic Prescribing in individuals with autism, dementia, learning disability, serious mental illness or living in a care home: A federated analysis of 59 million patients primary care records in situ using OpenSAFELY (2023) (0)
- A national audit of pancreatic enzyme prescribing in pancreatic cancer from 2015 to 2023 in England using OpenSAFELY-TPP (2023) (0)
- Liverpool Heart and Chest NHS Foundation Trust (2018) (0)
- Post all press releases online, and give them named authors (2014) (0)
- Barriers to Working With National Health Service England’s Open Data (Preprint) (2019) (0)
- Using data science to identify unusual treatment choices in England: illustrative findings of uncommon antipsychotics Pericyazine and Promazine (2022) (0)
- Systematic review of randomized placebo-controlled trials to aid individual patient choice What proportion of symptomatic side effects in patients taking statins are genuinely caused by the (2014) (0)
- Department of Error (2021) (0)
- O03: Effect modification of biologic survival by patient characteristics: a prospective cohort study from the British Association of Dermatologists Biologics and Immunomodulators Register (2022) (0)
- Nanoliposomal irinotecan in metastatic pancreatic cancer (2016) (0)
- The impact of COVID-19 on prescribing of pancreatic enzyme replacement therapy for people with unresectable pancreatic cancer in England. A cohort study using OpenSafely-TPP (2022) (0)
- Qualitative process evaluation (QUalitative Evaluation of a trial of ANtibiotics for chronic lung disease study) (2014) (0)
- Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study (2023) (0)
- Harnessing medicines data at low cost to deliver better and safer care (2021) (0)
- Authors’ reply to Aiyenigba and Weeks, Bahadur and colleagues, and Griffin and colleagues (2017) (0)
- Reply to Comment on ‘Impact of NICE guidance on tamoxifen prescribing in England 2011–2017: an interrupted time series analysis” (2018) (0)
- Expectant management in pregnancies with ruptured membranes (2016) (0)
- Cost-effectiveness analysis of antibiotics for chronic obstructive pulmonary disease exacerbations (2014) (0)
- Reported Outcomes of the Alexander Technique Lessons or Acupuncture Sessions for Persons With Chronic Neck Pain Article (2016) (0)
- Comparison of methods for predicting COVID-19-related death in the general population using the OpenSAFELY platform (2022) (0)
- 7 Producing data-driven tools (2018) (0)
- Pressure grows againsr homoeopathy in the UK. Commentary (2007) (0)
- Impact of Electronic Health Record Interface Design on Unsafe Prescribing of Ciclosporin, Tacrolimus, and Diltiazem: Cohort Study in English National Health Service Primary Care (Preprint) (2019) (0)
- Protocol for an OpenSAFELY cohort study collecting patient-reported outcome measures using the TPP Airmid smartphone application and linked big data to quantify the health and economic costs of long COVID (OpenPROMPT) (2023) (0)
- Recording of ’COVID-19 vaccine declined‘: a cohort study on 57.9 million National Health Service patients’ records in situ using OpenSAFELY, England, 8 December 2020 to 25 May 2021 (2022) (0)
- 201214 Ortho Tribune United Kingdom Edition (2019) (0)
- Background, aims of project and exemplar trials (2014) (0)
- Information technology system for flagging and data processing in point-of-care trials (2014) (0)
- Does a teaching session given to pharmacists with influence over the prescribing of a regional group of general practices affect the number of low-priority medicines prescribed? (2018) (0)
- Primary care coding activity related to the use of online consultation systems or remote consulting: an analysis of 53 million peoples' health records using OpenSAFELY (2023) (0)
- Meta-analyses of homoeopathy trials - Reply (2008) (0)
- Ben Goldacre: A great time to be alive (2019) (0)
- Seducing Vipers: Understanding and befriending evil (2007) (0)
- Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP (2023) (0)
- Implementation experiences with the exemplar trials (2014) (0)
- Good Clinical Practice guidelines and point-of-care trials (2014) (0)
This paper list is powered by the following services:
Other Resources About Ben Goldacre
What Schools Are Affiliated With Ben Goldacre?
Ben Goldacre is affiliated with the following schools:
What Are Ben Goldacre's Academic Contributions?
Ben Goldacre is most known for their academic work in the field of medical. They are also known for their academic work in the fields of and philosophy.
Ben Goldacre has made the following academic contributions:
